Dr. A david Rothner MD

Recommended Articles

• Common Antioxidant May Slow Multiple Sclerosis Progression

  To date, multiple sclerosis (MS), a chronic neurological condition, affects more than 2.3 million individuals worldwide. The immune system mistakenly attacks the myelin, which is the protective layer that surrounds the nerve fibers. This, in turn, disrupts the regular nerve signaling between the...

• Communicating with an Alzheimer's Patient

  Many aspects have been focused on and taken into consideration when it comes to Alzheimer's research. Additional studies that support and give a better understanding, list acceptance, and encourage a positive outlook are important for those with Alzheimer's. Although the disease does indeed progress...

• Research Gives Muscular Dystrophy Patients New Hope

  Regardless of the person’s age, sex, or where they are from, being told that they have a progressive disease like muscular dystrophy is devastating.  It means learning to live with a disease that makes muscles waste away.  For many, one of the coping mechanisms they turn to is to learn as much...

• Teen's Start-Up Is Leading the Fight in Alzheimer's Disease

  Teenager Victoria Da Conceicao is the CEO and founder of the Alzheimer’s organization named Brain Box. This initiative is a way for Victoria to fight for her grandmother who was diagnosed with Alzheimer’s. The initiative was first organized for Victoria’s grandmother, but it has since reached...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...

• What Is a Transorbital Lobotomy?

  Transorbital LobotomyTransorbital lobotomy was once considered as a form of neurosurgery that was labeled as "insane". A pioneer in this field was a Portuguese doctor named António Egas Moniz. He introduced frontal lobotomy in 1935 for certain cases of psychosis and won a Nobel Prize because of...